Our Pricing

Omeprazole BNFC Quick Reference Guide

Published on: June 03, 2026

This omeprazole BNFC paediatric dosing UK guide provides healthcare professionals and parents with evidence-based prescribing information for children requiring proton pump inhibitor therapy. Omeprazole remains the most widely prescribed PPI for paediatric gastro-oesophageal reflux disease (GORD) and peptic ulcer management in the UK, with clear BNFC guidance supporting safe administration across age groups [1].

Understanding Omeprazole in Paediatric Practice

Omeprazole belongs to the proton pump inhibitor (PPI) class and works by irreversibly blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells, reducing stomach acid production by up to 90% [1]. This mechanism makes it particularly effective for managing acid-related conditions in children, from neonates through to adolescents.

The British National Formulary for Children (BNFC) provides comprehensive age-specific dosing recommendations that account for developmental pharmacokinetic differences. Unlike adult prescribing, paediatric omeprazole dosing often requires weight-based calculations and careful consideration of formulation suitability [2].

Clinical evidence demonstrates that omeprazole effectively manages paediatric GORD symptoms, with studies showing significant improvement in irritability, feeding difficulties, and erosive oesophagitis in children aged 1 month to 16 years [2]. The medication is licensed for short-term treatment of reflux oesophagitis and symptomatic GORD in children over 1 year, though specialist prescribers may use it off-label in younger infants under hospital supervision.

BNFC Dosing Guidelines by Age and Weight

The BNFC stratifies omeprazole dosing according to patient age, body weight, and indication. For neonates and infants under 1 year with severe reflux oesophagitis, specialist paediatric guidance typically recommends 700 micrograms per kilogram once daily, increased if necessary to 1.4 mg per kilogram once daily for severe cases [1].

Children aged 1 to 11 years with GORD receive weight-based dosing: those weighing 10-20 kg typically start on 10 mg once daily, while children over 20 kg may receive 20 mg once daily. Treatment duration should not exceed 8 weeks without specialist review, and dose adjustments require careful monitoring of symptom control and side effects [2].

Adolescents aged 12 to 17 years generally follow adult dosing protocols, receiving 20 mg once daily for GORD or 40 mg once daily for severe oesophagitis or Helicobacter pylori eradication as part of triple therapy. All paediatric omeprazole prescriptions require clinical assessment by a UK prescriber to ensure appropriate indication and dosing.

Administration Considerations for Children

Omeprazole capsules should ideally be swallowed whole with water, preferably in the morning before food. For children unable to swallow capsules, the BNFC permits opening capsules and mixing the gastro-resistant granules with slightly acidic fluids like fruit juice or yoghurt, ensuring immediate consumption without chewing [1]. Alternatively, MUPS (multiple unit pellet system) dispersible tablets can be dispersed in non-carbonated water for easier administration in younger patients.

Omeprazole BNFC Paediatric Dosing vs Other PPIs

While omeprazole remains first-line for most paediatric acid-related conditions, the BNFC also lists alternative PPIs with distinct pharmacological profiles. Lansoprazole offers similar efficacy with potentially faster symptom relief in some children, whilst esomeprazole—the S-isomer of omeprazole—provides more predictable pharmacokinetics due to reduced first-pass metabolism [3].

Pantoprazole is licensed for children aged 12 years and over, making it less versatile than omeprazole for younger paediatric patients. The choice between PPIs often depends on formulation availability, individual response, and cost considerations, with omeprazole typically offering the most economical option whilst maintaining excellent efficacy [3].

Clinical trials comparing paediatric PPIs show comparable healing rates for erosive oesophagitis, with 60-80% of children achieving mucosal healing within 8 weeks regardless of which PPI is prescribed [2]. Your UK prescriber will select the most appropriate PPI based on your child's age, weight, symptoms, and any concurrent medications that may interact with specific proton pump inhibitors.

Common Paediatric Indications and Treatment Duration

The BNFC lists several licensed indications for paediatric omeprazole use, with gastro-oesophageal reflux disease representing the most common. Children with GORD may present with regurgitation, feeding difficulties, failure to thrive, or respiratory symptoms caused by acid aspiration [1]. Omeprazole effectively reduces acid exposure, allowing oesophageal healing and symptom resolution in most cases.

Peptic ulcer disease, though less common in children than adults, may require omeprazole therapy—particularly when associated with Helicobacter pylori infection or NSAID use. The BNFC recommends omeprazole as part of triple therapy eradication regimens, combining the PPI with two antibiotics for 7-14 days [2].

Treatment duration varies by indication: symptomatic GORD typically requires 4-8 weeks of therapy, whilst erosive oesophagitis may need 8-12 weeks for complete healing. Long-term maintenance therapy in children should only continue under specialist supervision, with regular review to assess ongoing need and monitor for potential adverse effects associated with prolonged acid suppression [3].

When to Seek Specialist Paediatric Gastroenterology Input

Children who fail to respond to appropriate-dose PPI therapy within 4-8 weeks require specialist assessment to exclude alternative diagnoses such as eosinophilic oesophagitis, cow's milk protein allergy, or anatomical abnormalities. Similarly, infants under 1 year with severe symptoms, children with alarm features (dysphagia, haematemesis, weight loss), or those requiring long-term acid suppression beyond 12 months should be referred to paediatric gastroenterology for further investigation and management planning [1].

Side Effects and Safety Considerations in Children

Omeprazole is generally well-tolerated in paediatric patients, with most children experiencing no significant adverse effects during short-term therapy. The most commonly reported side effects include headache, abdominal pain, diarrhoea, and constipation, affecting approximately 1-10% of children in clinical trials [2].

Long-term PPI use in children raises theoretical concerns about nutrient malabsorption, particularly calcium, magnesium, iron, and vitamin B12, due to sustained acid suppression affecting mineral ionisation and absorption. Whilst clinically significant deficiencies remain rare, children on prolonged omeprazole therapy may benefit from periodic monitoring of nutritional status and bone health [3].

Recent pharmacovigilance data has highlighted a potential association between PPI use and increased risk of gastrointestinal infections, including Clostridium difficile and community-acquired pneumonia, due to altered gastric pH affecting the stomach's antimicrobial barrier function. However, these risks must be balanced against the significant benefits of treating symptomatic acid-related disease, with prescribers using the lowest effective dose for the shortest necessary duration [3].

Accessing Omeprazole and Alternative Treatments Through Cured Pharmacy

Cured Pharmacy offers a comprehensive range of proton pump inhibitors for adults requiring acid reflux management, with all prescription medications dispensed following clinical assessment by UK-registered prescribers. Our Omeprazole Capsules start from £9.99, providing cost-effective treatment for eligible patients.

For those seeking alternative PPIs, we stock Esomeprazole 20mg from £9.99, Lansoprazole Capsules from £9.99, and Pantoprazole Gastro Resistant Tablets from £9.99. Branded options include Losec from £9.99 and Nexium Tablets 40mg from £9.99.

All prescription treatments require completion of our free online consultation, which takes under 3 minutes and ensures appropriate prescribing by our UK clinical team. We guarantee 100% discreet packaging, next-day delivery options, and the lowest prices in the UK, with transparent upfront pricing displayed before you begin your assessment. For paediatric prescriptions, we recommend consulting your child's GP or paediatrician, as our service currently focuses on adult patients aged 18 and over.

Why Choose Cured Pharmacy for Acid Reflux Treatment

As a fully registered UK online pharmacy (GPhC Registration Number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), we dispense only genuine UK-licensed medicines with full regulatory compliance. Our transparent pricing model means you'll see the exact cost before starting your consultation, with no hidden fees or subscription charges. Contact our team on (+44) 116 4646009 for any questions about our acid reflux treatment options.

Scientific References

1. Joint Formulary Committee. (2024). British National Formulary for Children (BNFC). London: BMJ Group, Pharmaceutical Press, and RCPCH Publications. [accessed 13 August 2026]
2. Gilger, M. A., et al. (2008). Safety and Tolerability of Esomeprazole in Children with Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology and Nutrition, 46(5), 524-533. https://doi.org/10.1097/MPG.0b013e31815ce542 [accessed 13 August 2026]
3. Rosen, R., et al. (2018). Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition, 66(3), 516-554. https://doi.org/10.1097/MPG.0000000000001889 [accessed 13 August 2026]
4. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.